Serial Number | 97623963 |
Word Mark | FOPAL |
Filing Date | Friday, October 7, 2022 |
Status | 653 - SUSPENSION LETTER - MAILED |
Status Date | Tuesday, October 1, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of the design of a butterfly with two sets of two overlapping wings in yellow and orange shading to the left and to the right of the body of the butterfly which is created by the negative space between the left and right sets of wings. All of the butterfly design appears to the right of the stylized blue word "FOPAL". The white in the drawing represents background and is not a feature of the mark. |
Indication of Colors claimed | The color(s) yellow, orange, and blue is/are claimed as a feature of the mark. |
Goods and Services | Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; conducting business and market research surveys in the fields of pharmaceuticals and clinical trials |
Goods and Services | Providing an online computer database featuring a compilation of medical information and patient records being medical information; medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; medical assistance services, namely, providing support in the observation, monitoring, adherence and medical treatments on patients; health assessment services, namely, conducting health-related surveys and questionnaires that produce medical treatment information; conducting medical information surveys and questionnaires in the fields of disease and treatment, namely, conducting health surveys of patients with Fibrodysplasia ossificans progressiva (FOP) disease for medical purposes |
Goods and Services | Providing a website featuring medical and scientific educational information in the fields of pharmaceuticals and clinical trials; providing medical and scientific research information in the field of Fibrodysplasia ossificans progressiva (FOP) disease and treatment |
International Class | 035 - Advertising; business management; business administration; office functions. |
US Class Codes | 100, 101, 102 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 24, 2022 |
Primary Code | 035 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 24, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Monday, October 24, 2022 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Clementia Pharmaceuticals Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Montreal, Quebec H3B2V6 CA |
Event Date | Event Description |
Tuesday, October 11, 2022 | NEW APPLICATION ENTERED |
Monday, October 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, October 25, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, May 8, 2023 | ASSIGNED TO EXAMINER |
Thursday, May 11, 2023 | NON-FINAL ACTION WRITTEN |
Thursday, May 11, 2023 | NON-FINAL ACTION E-MAILED |
Thursday, May 11, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, August 9, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, August 9, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, August 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, August 11, 2023 | SUSPENSION LETTER WRITTEN |
Friday, August 11, 2023 | LETTER OF SUSPENSION E-MAILED |
Friday, August 11, 2023 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, December 19, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Tuesday, December 19, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Tuesday, December 19, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, February 27, 2024 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Wednesday, February 14, 2024 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
Tuesday, February 27, 2024 | SUSPENSION INQUIRY WRITTEN |
Tuesday, February 27, 2024 | INQUIRY TO SUSPENSION E-MAILED |
Tuesday, September 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, September 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, September 10, 2024 | ASSIGNED TO LIE |
Tuesday, October 1, 2024 | LETTER OF SUSPENSION E-MAILED |
Tuesday, October 1, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Tuesday, October 1, 2024 | SUSPENSION LETTER WRITTEN |
Tuesday, April 16, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |